Joselito® and lowering of LDL‐cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
Abstract Following an application from Cárnicas Joselito S.A. pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Spain, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim r...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-07-01
|
| Series: | EFSA Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.2903/j.efsa.2024.8862 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839628914547228672 |
|---|---|
| author | EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA) Dominique Turck Torsten Bohn Jacqueline Castenmiller Stefaan De Henauw Karen Ildico Hirsch‐Ernst Helle Katrine Knutsen Alexandre Maciuk Inge Mangelsdorf Harry J. McArdle Androniki Naska Kristina Pentieva Frank Thies Sophia Tsabouri Marco Vinceti Jean‐Louis Bresson Thibault Fiolet Alfonso Siani |
| author_facet | EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA) Dominique Turck Torsten Bohn Jacqueline Castenmiller Stefaan De Henauw Karen Ildico Hirsch‐Ernst Helle Katrine Knutsen Alexandre Maciuk Inge Mangelsdorf Harry J. McArdle Androniki Naska Kristina Pentieva Frank Thies Sophia Tsabouri Marco Vinceti Jean‐Louis Bresson Thibault Fiolet Alfonso Siani |
| author_sort | EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA) |
| collection | DOAJ |
| description | Abstract Following an application from Cárnicas Joselito S.A. pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Spain, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to ‘Joselito ham increases antioxidant substances in the body, reduces blood pressure and plasma triglycerides, decreases oxidative stress and prevents effect in diseases related to the cardiovascular and intestinal systems’. The scope of the application was proposed to fall under a health claim referring to disease risk reduction. The food constituent that is the subject of the health claim is Joselito, an Iberian ham characterised by a high content of oleic acid. The Panel considers that the food is sufficiently characterised. The Panel considers that lowering of LDL‐cholesterol concentration and blood pressure is a beneficial effect by decreasing the risk of coronary heart disease. Upon a request from EFSA, the applicant identified one human intervention study as being pertinent to the claim. However, due to methodological limitations, the Panel considers that no conclusions can be drawn from this study for the scientific substantiation of the claim. The Panel notes that no human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the intake of Joselito® ham and the reduction of LDL‐cholesterol concentration or blood pressure. |
| format | Article |
| id | doaj-art-ea7e764b485f4860a9a2e43f1026a9c0 |
| institution | Matheson Library |
| issn | 1831-4732 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | EFSA Journal |
| spelling | doaj-art-ea7e764b485f4860a9a2e43f1026a9c02025-07-15T09:06:43ZengWileyEFSA Journal1831-47322024-07-01227n/an/a10.2903/j.efsa.2024.8862Joselito® and lowering of LDL‐cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA)Dominique TurckTorsten BohnJacqueline CastenmillerStefaan De HenauwKaren Ildico Hirsch‐ErnstHelle Katrine KnutsenAlexandre MaciukInge MangelsdorfHarry J. McArdleAndroniki NaskaKristina PentievaFrank ThiesSophia TsabouriMarco VincetiJean‐Louis BressonThibault FioletAlfonso SianiAbstract Following an application from Cárnicas Joselito S.A. pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Spain, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to ‘Joselito ham increases antioxidant substances in the body, reduces blood pressure and plasma triglycerides, decreases oxidative stress and prevents effect in diseases related to the cardiovascular and intestinal systems’. The scope of the application was proposed to fall under a health claim referring to disease risk reduction. The food constituent that is the subject of the health claim is Joselito, an Iberian ham characterised by a high content of oleic acid. The Panel considers that the food is sufficiently characterised. The Panel considers that lowering of LDL‐cholesterol concentration and blood pressure is a beneficial effect by decreasing the risk of coronary heart disease. Upon a request from EFSA, the applicant identified one human intervention study as being pertinent to the claim. However, due to methodological limitations, the Panel considers that no conclusions can be drawn from this study for the scientific substantiation of the claim. The Panel notes that no human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the intake of Joselito® ham and the reduction of LDL‐cholesterol concentration or blood pressure.https://doi.org/10.2903/j.efsa.2024.8862hamhealth claimsIberian hamJoselito |
| spellingShingle | EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA) Dominique Turck Torsten Bohn Jacqueline Castenmiller Stefaan De Henauw Karen Ildico Hirsch‐Ernst Helle Katrine Knutsen Alexandre Maciuk Inge Mangelsdorf Harry J. McArdle Androniki Naska Kristina Pentieva Frank Thies Sophia Tsabouri Marco Vinceti Jean‐Louis Bresson Thibault Fiolet Alfonso Siani Joselito® and lowering of LDL‐cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 EFSA Journal ham health claims Iberian ham Joselito |
| title | Joselito® and lowering of LDL‐cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_full | Joselito® and lowering of LDL‐cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_fullStr | Joselito® and lowering of LDL‐cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_full_unstemmed | Joselito® and lowering of LDL‐cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_short | Joselito® and lowering of LDL‐cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_sort | joselito r and lowering of ldl cholesterol concentration blood pressure and reduction of coronary heart disease risk evaluation of a health claim pursuant to article 14 of regulation ec no 1924 2006 |
| topic | ham health claims Iberian ham Joselito |
| url | https://doi.org/10.2903/j.efsa.2024.8862 |
| work_keys_str_mv | AT efsapanelonnutritionnovelfoodsandfoodallergensnda joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT dominiqueturck joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT torstenbohn joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT jacquelinecastenmiller joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT stefaandehenauw joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT karenildicohirschernst joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT hellekatrineknutsen joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT alexandremaciuk joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT ingemangelsdorf joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT harryjmcardle joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT andronikinaska joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT kristinapentieva joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT frankthies joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT sophiatsabouri joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT marcovinceti joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT jeanlouisbresson joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT thibaultfiolet joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 AT alfonsosiani joselitoandloweringofldlcholesterolconcentrationbloodpressureandreductionofcoronaryheartdiseaseriskevaluationofahealthclaimpursuanttoarticle14ofregulationecno19242006 |